Skip to main content
Sister Publication Links
  • ModernHealthcare.com
Subscribe
  • My Account
  • Login
  • Register
  • Consumer Centric
  • Provider/Payer Centric
  • Funding/M&A
  • Policy
  • Data
  • Opinions
  • Advertise
MENU
Breadcrumb
  1. Home
  2. Policy
April 28, 2022 05:02 PM

Cerebral faces lawsuit from former executive

Gabriel Perna
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    lawsuit

    Cerebral, a direct-to-consumer mental telehealth company, is facing a lawsuit from a former executive who alleges the company fired him for speaking out against its unlawful business practices.

    Matthew Truebe, former vice president of product and engineering at Cerebral, alleges that the company put profits before patient safety. He alleges the company planned to increase customer retention by prescribing stimulants for attention deficit hyperactivity disorder (ADHD) to 100% of its patients. 

    The lawsuit also alleges that Cerebral had 2,000 duplicate shipping addresses, which suggested patients were setting up multiple accounts to obtain additional medication from prescribers. He alleges that when he brought this up to Cerebral CEO Kyle Robertson and other executives, it was ignored and called a low-priority problem. 

    Truebe also alleged “employees and former employees could gain unauthorized access to confidential patient medical information” at Cerebral, another problem which he alleges went ignored. When he spoke out against these practices, Truebe alleges the company ordered him to sign an amended employee agreement that reduced his stock options and didn’t allow him to speak out about his allegations. He alleges he was later written a poor review and fired for not signing the agreement, one day before his stock options had vested. 

    The lawsuit comes at a time when Cerebral, Done Health and other digital mental health companies are facing scrutiny for their prescription practices. A recent report in The Wall Street Journal alleges that Done and Cerebral’s prescription habits caught the eye of national pharmacy chains, including CVS Health, Walmart and Walgreens, which reportedly have blocked and delayed some prescriptions from the two companies. 

    In response to the lawsuit, a Cerebral spokesperson said, "We do not comment on the specifics of pending litigation but we believe that the claims alleged in the complaint are without merit. We intend to vigorously defend this matter."

    Truebe filed the lawsuit in the Superior Court of California, County of San Francisco. 

    Cerebral received a $300 million funding round in December and is valued at nearly $5 billion.  

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    2015_01_29_EHR_stock_getty_doctor hands touching tablet_i.jpg
    Navigating data guidelines and regulations
    three-gavels_i copy_i.png
    Change Healthcare-Olive lawsuit could have big effect on noncompetes, lawyers say
    Sponsored Content
    Get Newsletters

    Newsletters for providers, payers, investors and innovators across the digital health ecosystem. Sign up to get breaking digital health news including digital health deals, M&A, finance, IPOs. as they happen, right to your inbox.

    Buy Q1 Report Today
    Quarterly Report Cover Image

    The Digital Health Funding and M&A Q1 report delivers the most comprehensive insight and data around the financial health of the sector.

    Purchase Today
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Digital Health Business & Technology delivers news, data, insights and analysis covering the entire digital healthcare ecosystem.

    Logo
    Contact Us

    (877) 812-1581

    Email us

     

    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    Resources
    • About Us
    • Contact Us
    • Staff
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Digital Health Business & Technology
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • Consumer Centric
    • Provider/Payer Centric
    • Funding/M&A
    • Policy
    • Data
    • Opinions
    • Advertise